Yelin Edward, Murphy Louise, Cisternas Miriam G, Foreman Aimee J, Pasta David J, Helmick Charles G
University of California, San Francisco 94143-0920, USA.
Arthritis Rheum. 2007 May;56(5):1397-407. doi: 10.1002/art.22565.
To obtain estimates of medical care expenditures and earnings losses associated with arthritis and other rheumatic conditions and the increment in such costs attributable to arthritis and other rheumatic conditions in the US in 2003, and to compare these estimates with those from 1997.
Estimates for 2003 were derived from the Medical Expenditures Panel Survey (MEPS), a national probability sample of households. We tabulated medical care expenditures of adult MEPS respondents, stratified by arthritis and comorbidity status, and used regression techniques to estimate the increment of medical care expenditures attributable to arthritis and other rheumatic conditions. We also estimated the earnings losses sustained by working-age adults with arthritis and other rheumatic conditions. Estimates for 2003 were compared with those from 1997, inflated to 2003 terms.
In 2003, there were 46.1 million adults with arthritis and other rheumatic conditions (versus 36.8 million in 1997). Adults with arthritis and other rheumatic conditions incurred mean medical care expenditures of $6,978 in 2003 (versus $6,346 in 1997), of which $1,635 was for prescriptions ($899 in 1997). Expenditures for adults with arthritis and other rheumatic conditions totaled $321.8 billion in 2003 ($233.5 billion in 1997). In 2003, the mean increment in medical care expenditures attributable to arthritis and other rheumatic conditions was $1,752 ($1,762 in 1997), for a total of $80.8 billion ($64.8 billion in 1997). Persons with arthritis and other rheumatic conditions ages 18-64 years earned $3,613 less than other persons (versus $4,551 in 1997), for a total of $108.0 billion (versus $99.0 billion). Of this amount, $1,590 was attributable to arthritis and other rheumatic conditions (versus $1,946 in 1997), for a total of $47.0 billion ($43.3 billion in 1997).
Our findings indicate that the increase in medical care expenditures and earnings losses between 1997 and 2003 is due more to an increase in the number of persons with arthritis and other rheumatic conditions than to costs per case.
获取2003年美国与关节炎和其他风湿性疾病相关的医疗保健支出及收入损失估计值,以及归因于关节炎和其他风湿性疾病的此类成本增量,并将这些估计值与1997年的进行比较。
2003年的估计值来自医疗支出面板调查(MEPS),这是一个全国性的家庭概率样本。我们将成年MEPS受访者的医疗保健支出制成表格,按关节炎和合并症状况分层,并使用回归技术来估计归因于关节炎和其他风湿性疾病的医疗保健支出增量。我们还估计了患有关节炎和其他风湿性疾病的适龄成年人所遭受的收入损失。将2003年的估计值与1997年的进行比较,并按2003年的价格水平进行调整。
2003年,有4610万成年人患有关节炎和其他风湿性疾病(1997年为3680万)。2003年,患有关节炎和其他风湿性疾病的成年人平均医疗保健支出为6978美元(1997年为6346美元),其中1635美元用于处方药(1997年为899美元)。2003年,患有关节炎和其他风湿性疾病的成年人的支出总计3218亿美元(1997年为2335亿美元)。2003年,归因于关节炎和其他风湿性疾病的医疗保健支出平均增量为1752美元(1997年为1762美元),总计808亿美元(1997年为648亿美元)。18至64岁患有关节炎和其他风湿性疾病的人比其他人少挣3613美元(1997年为4551美元),总计1080亿美元(1997年为990亿美元)。其中,1590美元归因于关节炎和其他风湿性疾病(1997年为1946美元),总计470亿美元(1997年为433亿美元)。
我们的研究结果表明,1997年至2003年期间医疗保健支出和收入损失的增加,更多是由于患有关节炎和其他风湿性疾病的人数增加,而非每个病例的成本增加。